This announcement is a separate document:
健帆生物：国浩律师（深圳）事务所关于公司2021年限制性股票激励计划回购注销部分限制性股票相关事项之法律意见书
Jafron Biomedical: Legal Opinion of Guo Hao Lawyers (Shenzhen) Firm on matters relating to the repurchase and cancellation of some restricted stocks in the Company's 2021 Restricted Stock Incentive Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.